AusCann Group Holdings Ltd (ASX:AC8) (“AusCann” or “the Company”) welcomes the Federal Government announcement today from Health Minister Greg Hunt to allow manufactured cannabinoid medicines to be exported from Australia.
This puts AusCann in a very valuable position as the only company with the full set of the necessary licences to grow and manufacture cannabinoid medicines in Australia. AusCann has the only established TGA licensed manufacturing facility through their partnership with Tasmanian Alkaloids.
AusCann, Managing Director Elaine Darby said “This is a win for the Australian Cannabis industry and Australian patients as it allows us to produce cost effective products at scale. We are perfectly positioned to create high value export products from AusCann and have the international relationships in place including Canopy, the largest producer in North America and also our largest shareholder in AusCann.”
For further information please download PDF attached:
Download this document
